Cherie P Erkmen1,2, Farouk Dako3, Ryan Moore4, Chandra Dass3, Mark G Weiner5, Larry R Kaiser1, Grace X Ma6,7. 1. Department of Thoracic Medicine and Surgery, Lewis Katz School of Medicine at Temple University, Parkinson Pavilion, Zone C, Suite 501, 3401 N. Broad Street, Philadelphia, PA, 19140, USA. 2. Center for Asian Health, Lewis Katz School of Medicine at Temple University, Kresge Science Hall, Suite 320, 3440 N. Broad Street, Philadelphia, PA, 19140, USA. 3. Department of Radiology, Lewis Katz School of Medicine at Temple University, Philadelphia, USA. 4. Department of Surgery, Lewis Katz School of Medicine at Temple University, Philadelphia, USA. 5. Department of Clinical Sciences, Lewis Katz School of Medicine at Temple University, Philadelphia, USA. 6. Department of Clinical Sciences, Lewis Katz School of Medicine at Temple University, Philadelphia, USA. grace.ma@temple.edu. 7. Center for Asian Health, Lewis Katz School of Medicine at Temple University, Kresge Science Hall, Suite 320, 3440 N. Broad Street, Philadelphia, PA, 19140, USA. grace.ma@temple.edu.
Abstract
PURPOSE: Our aim was to develop a novel approach for lung cancer screening among a diverse population that integrates the Centers for Medicare and Medicaid Services (CMS) recommended components including shared decision making (SDM), low-dose CT (LDCT), reporting of results in a standardized format, smoking cessation, and arrangement of follow-up care. METHODS: Between October of 2015 and March of 2018, we enrolled patients, gathered data on demographics, delivery of SDM, reporting of LDCT results using Lung-RADS, discussion of results, and smoking cessation counseling. We measured adherence to follow-up care, cancer diagnosis, cancer treatment, and smoking cessation at 2 years after initial LDCT. RESULTS: We enrolled 505 patients who were 57% African American, 30% Caucasian, 13% Hispanic, < 1% Asian, and 61% were active smokers. All participants participated in SDM, 88.1% used a decision aid, and 96.1% proceeded with LDCT. Of 496 completing LDCT, all received a discussion about results and follow-up recommendations. Overall, 12.9% had Lung-RADS 3 or 4, and 3.2% were diagnosed with lung cancer resulting in a false-positive rate of 10.7%. All 48 patients with positive screens but no cancer diagnosis adhered to follow-up care at 1 year, but only 35.4% adhered to recommended follow-up care at 2 years. The annual follow-up for patients with negative lung cancer screening results (Lung-RADS 1 and 2) was only 23.7% after one year and 2.8% after 2 years. All active smokers received smoking cessation counseling, but only 11% quit smoking. CONCLUSION: The findings show that an integrated lung cancer screening program can be safely implemented in a diverse population, but adherence to annual screening is poor.
PURPOSE: Our aim was to develop a novel approach for lung cancer screening among a diverse population that integrates the Centers for Medicare and Medicaid Services (CMS) recommended components including shared decision making (SDM), low-dose CT (LDCT), reporting of results in a standardized format, smoking cessation, and arrangement of follow-up care. METHODS: Between October of 2015 and March of 2018, we enrolled patients, gathered data on demographics, delivery of SDM, reporting of LDCT results using Lung-RADS, discussion of results, and smoking cessation counseling. We measured adherence to follow-up care, cancer diagnosis, cancer treatment, and smoking cessation at 2 years after initial LDCT. RESULTS: We enrolled 505 patients who were 57% African American, 30% Caucasian, 13% Hispanic, < 1% Asian, and 61% were active smokers. All participants participated in SDM, 88.1% used a decision aid, and 96.1% proceeded with LDCT. Of 496 completing LDCT, all received a discussion about results and follow-up recommendations. Overall, 12.9% had Lung-RADS 3 or 4, and 3.2% were diagnosed with lung cancer resulting in a false-positive rate of 10.7%. All 48 patients with positive screens but no cancer diagnosis adhered to follow-up care at 1 year, but only 35.4% adhered to recommended follow-up care at 2 years. The annual follow-up for patients with negative lung cancer screening results (Lung-RADS 1 and 2) was only 23.7% after one year and 2.8% after 2 years. All active smokers received smoking cessation counseling, but only 11% quit smoking. CONCLUSION: The findings show that an integrated lung cancer screening program can be safely implemented in a diverse population, but adherence to annual screening is poor.
Entities:
Keywords:
Adherence to lung cancer screening; African American; Diverse population; Low-dose CT scan; Lung cancer screening
Authors: Paul F Pinsky; David S Gierada; William Black; Reginald Munden; Hrudaya Nath; Denise Aberle; Ella Kazerooni Journal: Ann Intern Med Date: 2015-04-07 Impact factor: 25.391
Authors: Nichole T Tanner; Mulugeta Gebregziabher; Chanita Hughes Halbert; Elizabeth Payne; Leonard E Egede; Gerard A Silvestri Journal: Am J Respir Crit Care Med Date: 2015-07-15 Impact factor: 21.405
Authors: Ella A Kazerooni; John H M Austin; William C Black; Debra S Dyer; Todd R Hazelton; Ann N Leung; Michael F McNitt-Gray; Reginald F Munden; Sudhakar Pipavath Journal: J Thorac Imaging Date: 2014-09 Impact factor: 3.000
Authors: Denise R Aberle; Amanda M Adams; Christine D Berg; William C Black; Jonathan D Clapp; Richard M Fagerstrom; Ilana F Gareen; Constantine Gatsonis; Pamela M Marcus; JoRean D Sicks Journal: N Engl J Med Date: 2011-06-29 Impact factor: 91.245
Authors: Suresh H Moolgavkar; Theodore R Holford; David T Levy; Chung Yin Kong; Millenia Foy; Lauren Clarke; Jihyoun Jeon; William D Hazelton; Rafael Meza; Frank Schultz; William McCarthy; Robert Boer; Olga Gorlova; G Scott Gazelle; Marek Kimmel; Pamela M McMahon; Harry J de Koning; Eric J Feuer Journal: J Natl Cancer Inst Date: 2012-03-14 Impact factor: 13.506
Authors: Lisa Carter-Harris; James E Slaven; Patrick O Monahan; Rivienne Shedd-Steele; Nasser Hanna; Susan M Rawl Journal: Prev Med Rep Date: 2018-02-03
Authors: Harris Majeed; Hong Zhu; Sarah A Williams; Heidi A Hamann; Vijaya Subbu Natchimuthu; Jessica Lee; Noel O Santini; Travis Browning; Tanushree Prasad; Joyce O Adesina; Minh Do; David Balis; Juana Gamarra de Willams; Ellen Kitchell; David H Johnson; Simon J Craddock Lee; David E Gerber Journal: Clin Lung Cancer Date: 2022-04-29 Impact factor: 4.840
Authors: Roger Y Kim; Katharine A Rendle; Nandita Mitra; Chelsea A Saia; Christine Neslund-Dudas; Robert T Greenlee; Andrea N Burnett-Hartman; Stacey A Honda; Michael J Simoff; Marilyn M Schapira; Jennifer M Croswell; Rafael Meza; Debra P Ritzwoller; Anil Vachani Journal: Ann Am Thorac Soc Date: 2022-09